Skip to main content
Log in

Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes

  • CASE REPORT
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

A 56-year-old-man presented with syncope and torsades de pointes secondary to methadone-induced QT prolongation. After transition from methadone to buprenorphine, a partial μ-opiate-receptor agonist and a κ-opiate-receptor antagonist, the QT normalized and ventricular arrhythmias resolved. Buprenorphine should be used for opiate dependence and chronic pain in patients with methadone-induced QT prolongation and as first line therapy in patients with risk factors for torsades de pointes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Fudala, P. J., Bridge, T. P., Herbert, S., Buprenorphine/Naloxone Collaborative Study Group, et al. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. The New England Journal of Medicine, 349, 949–958.

    Article  PubMed  CAS  Google Scholar 

  2. Martell, B. A., Arnsten, J. H., Krantz, M. J., & Gourevitch, M. N. (2005). Impact of methadone treatment on cardiac repolarization and conduction in opioid users. The American Journal of Cardiology, 95, 915–918.

    Article  PubMed  CAS  Google Scholar 

  3. Gupta, A., Lawrence, A. T., Krishnan, K., Kavinsky, C. J., & Trohman, R. G. (2007). Current concepts in the mechanisms and management of drug-induced QT prolongation and torsades de pointes. American Heart Journal, 153, 891–899.

    Article  PubMed  Google Scholar 

  4. Chugh, S. S., Socoteanu, C., Reinier, K., Waltz, J., Jui, J., & Gunson, K. (2008). A community-based evaluation of sudden death with therapeutic levels of methadone. The American Journal of Medicine, 121, 66–71.

    Article  PubMed  CAS  Google Scholar 

  5. Fanoe, S., Hvidt, C., Ege, P., & Jensen, G. B. (2007). Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart (British Cardiac Society), 93, 1051–1055.

    CAS  Google Scholar 

  6. Baer, J. R., Best, A. M., Pade, P. A., & McCance-Katz, E. F. (2006). Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients. The Annals of Pharmacotherapy, 40, 392–396.

    Article  Google Scholar 

  7. Wedam, E. F., Bigelow, G. E., Johnson, R. E., Nuzzo, P. A., & Haigney, M. C. P. (2007). QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Archives of Internal Medicine, 167, 2469–2475.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sam Hanon.

Additional information

The authors have no conflicts of interest or financial disclosures.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esses, J.L., Rosman, J., Do, L.T. et al. Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes. J Interv Card Electrophysiol 23, 117–119 (2008). https://doi.org/10.1007/s10840-008-9280-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-008-9280-8

Keywords

Navigation